Literature DB >> 17943156

Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate.

S Aime, C Canavese, P Stratta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17943156     DOI： 10.1038/sj.ki.5002503

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  3 in total

1.  Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH 3T3 cells.

Authors:  Li-Juan Fu; Jin-Xia Li; Xiao-Gai Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2008-10-25       Impact factor: 3.358

Review 2.  Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.

Authors:  Stephen J P Damment; Michael Pennick
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

3.  Effect of high-protein meals during hemodialysis combined with lanthanum carbonate in hypoalbuminemic dialysis patients: findings from the FrEDI randomized controlled trial.

Authors:  Connie M Rhee; Amy S You; Tara Koontz Parsons; Amanda R Tortorici; Rachelle Bross; David E St-Jules; Jennie Jing; Martin L Lee; Debbie Benner; Csaba P Kovesdy; Rajnish Mehrotra; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2017-07-01       Impact factor: 5.992
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.